Correlation Between Dyne Therapeutics and Neurosense Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dyne Therapeutics and Neurosense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyne Therapeutics and Neurosense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyne Therapeutics and Neurosense Therapeutics, you can compare the effects of market volatilities on Dyne Therapeutics and Neurosense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyne Therapeutics with a short position of Neurosense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyne Therapeutics and Neurosense Therapeutics.

Diversification Opportunities for Dyne Therapeutics and Neurosense Therapeutics

-0.06
  Correlation Coefficient

Good diversification

The 3 months correlation between Dyne and Neurosense is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Dyne Therapeutics and Neurosense Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurosense Therapeutics and Dyne Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyne Therapeutics are associated (or correlated) with Neurosense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurosense Therapeutics has no effect on the direction of Dyne Therapeutics i.e., Dyne Therapeutics and Neurosense Therapeutics go up and down completely randomly.

Pair Corralation between Dyne Therapeutics and Neurosense Therapeutics

Considering the 90-day investment horizon Dyne Therapeutics is expected to generate 49.61 times less return on investment than Neurosense Therapeutics. In addition to that, Dyne Therapeutics is 1.5 times more volatile than Neurosense Therapeutics. It trades about 0.0 of its total potential returns per unit of risk. Neurosense Therapeutics is currently generating about 0.12 per unit of volatility. If you would invest  109.00  in Neurosense Therapeutics on November 18, 2024 and sell it today you would earn a total of  7.00  from holding Neurosense Therapeutics or generate 6.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Dyne Therapeutics  vs.  Neurosense Therapeutics

 Performance 
       Timeline  
Dyne Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Dyne Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Neurosense Therapeutics 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Neurosense Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Neurosense Therapeutics may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Dyne Therapeutics and Neurosense Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dyne Therapeutics and Neurosense Therapeutics

The main advantage of trading using opposite Dyne Therapeutics and Neurosense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyne Therapeutics position performs unexpectedly, Neurosense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurosense Therapeutics will offset losses from the drop in Neurosense Therapeutics' long position.
The idea behind Dyne Therapeutics and Neurosense Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences